🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multicenter, open-label trial to evaluate the safety and ph...
Status
Completed
Location
Hokkaido University Hospital
Start Date
2016-07-29
Trial ID
NCT02870309
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ARALAST NP A1PI au...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-03-08
Trial ID
NCT04440488
Treatments Being Tested
Chronic Obstructive Pulmonary Disease (COPD)-patients (caused by smoking-le...
Status
Completed
Location
Klinikum Berchtesgadener Land
Start Date
2010-02
Trial ID
NCT01380626
Treatments Being Tested
This is a multi-center, open-label study to evaluate the long-term safety o...
Status
Completed
Location
Hiroskai University Hospital
Start Date
2016-07-29
Trial ID
NCT02870348
Treatments Being Tested
The purpose of the study is to evaluate the safety and efficacy of GLASSIA ...
Status
Terminated
Location
Georgia Cancer Center
Start Date
2017-04-26
Trial ID
NCT02956122
Treatments Being Tested
The drug Alpha-1 Antitrypsin (AAT, Aralast NP) is being tested in this stud...
Status
Terminated
Location
RADY Children's Hospital (University of California, San Diego)
Start Date
2010-10
Trial ID
NCT01183468
Treatments Being Tested
The primary objective is to determine if the medication Carbamazepine, can ...
Status
Terminated
Location
Washington University in St. Louis School of Medicine
Start Date
2012-01
Trial ID
NCT01379469
Treatments Being Tested
Alpha 1-antitrypsin-deficient individuals develop severe destructive lung d...
Status
Completed
Location
National Heart, Lung and Blood Institute (NHLBI)
Start Date
1995-05
Trial ID
NCT00001462
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Research Site 1
Start Date
2018-03-12
Trial ID
NCT03362242
Treatments Being Tested
The purpose of this clinical study is to assess the safety and tolerability...
Status
Completed
Location
National Jewish Medical and Research Center
Start Date
2006-06
Trial ID
NCT00301366
Treatments Being Tested